Management of COVID-19 Coagulopathy in a Patient with Severe Haemophilia A
Clicks: 134
ID: 269238
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Popular Article
30.0
/100
134 views
19 readers
AI Quality Assessment
Not analyzed
Readership in this journal
PopularRanked #16 of 25 articles by views in acta haematologica
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
A 54-year-old man with a long history of severe haemophilia A treated prophylactically with efmoroctocog alpha (3,000 IU twice weekly) was diagnosed with COVID-19 infection. He had multiple risk factors for COVID-19 severity including obesity, diabetes ...
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (35 words).
Try re-searching for a better abstract.
| Reference Key |
hermansactamanagement
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | João Pinto Pereira, Philippe Hantson, Ludovic Gerard, Xavier Wittebole, Pierre-François Laterre, Catherine Lambert, Cédric Hermans;João Pinto Pereira;Philippe Hantson;Ludovic Gerard;Xavier Wittebole;Pierre-François Laterre;Catherine Lambert;Cédric Hermans; |
| Journal | acta haematologica |
| Year | Year not found |
| DOI |
10.1159/000510591
|
| URL | |
| Keywords |
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.